News | June 08, 2022
Halozyme announces commercial launch of testosterone undecanoate 'TLANDO'
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
Under the agreement, Apotex’s branded division, Searchlight Pharma, will seek regulatory approval and handle marketing and distribution in Canada
Subscribe To Our Newsletter & Stay Updated
